Sophia Genetics Sa Stock Performance
| SOPH Stock | USD 4.73 0.13 2.83% |
Sophia Genetics has a performance score of 1 on a scale of 0 to 100. The entity has a beta of 1.78, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Sophia Genetics will likely underperform. Sophia Genetics SA right now has a risk of 4.79%. Please validate Sophia Genetics skewness, and the relationship between the value at risk and day median price , to decide if Sophia Genetics will be following its existing price patterns.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Sophia Genetics SA are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak basic indicators, Sophia Genetics may actually be approaching a critical reversion point that can send shares even higher in January 2026. ...more
Actual Historical Performance (%)
One Day Return 2.83 | Five Day Return 0.85 | Year To Date Return 48.28 | Ten Year Return (71.78) | All Time Return (71.78) |
1 | SOPHiA Genetics GAAP EPS of -0.30 misses by 0.06, revenue of 19.5M beats by 1.37M | 11/04/2025 |
2 | SOPHiA GENETICS S.A. Q3 2025 Earnings Call Transcript | 11/05/2025 |
3 | Complete Genomics and SOPHiA GENETICS Announce Integration of MSK-IMPACT and MSK-ACCESS Assays on DNBSEQ-T1 Platform at AMP 2025 | 11/11/2025 |
4 | Why SOPHiA GENETICS SA stock could rally strongly - Trade Performance Summary Precise Buy Zone Tips - newser.com | 11/19/2025 |
5 | Is SOPHiA GENETICS SA stock vulnerable to rate hikes - Quarterly Portfolio Review Risk Managed Investment Strategies - Newser | 12/04/2025 |
6 | Can SOPHiA GENETICS SA stock maintain growth trajectory - Watch List Stock Market Timing Techniques - | 12/18/2025 |
| Begin Period Cash Flow | 123.3 M | |
| Total Cashflows From Investing Activities | -8.2 M |
Sophia Genetics Relative Risk vs. Return Landscape
If you would invest 476.00 in Sophia Genetics SA on September 30, 2025 and sell it today you would lose (3.00) from holding Sophia Genetics SA or give up 0.63% of portfolio value over 90 days. Sophia Genetics SA is currently generating 0.1001% in daily expected returns and assumes 4.7949% risk (volatility on return distribution) over the 90 days horizon. In different words, 43% of stocks are less volatile than Sophia, and 98% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Sophia Genetics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sophia Genetics' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Sophia Genetics SA, and traders can use it to determine the average amount a Sophia Genetics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0209
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | SOPH | Huge Risk |
| Negative Returns |
Based on monthly moving average Sophia Genetics is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sophia Genetics by adding it to a well-diversified portfolio.
Sophia Genetics Fundamentals Growth
Sophia Stock prices reflect investors' perceptions of the future prospects and financial health of Sophia Genetics, and Sophia Genetics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Sophia Stock performance.
| Return On Equity | -0.86 | ||||
| Return On Asset | -0.26 | ||||
| Profit Margin | (1.02) % | ||||
| Operating Margin | (0.92) % | ||||
| Current Valuation | 302.68 M | ||||
| Shares Outstanding | 67.85 M | ||||
| Price To Book | 5.29 X | ||||
| Price To Sales | 4.38 X | ||||
| Revenue | 65.17 M | ||||
| Gross Profit | 49.49 M | ||||
| EBITDA | (50.76 M) | ||||
| Net Income | (61.27 M) | ||||
| Cash And Equivalents | 216.61 M | ||||
| Cash Per Share | 3.38 X | ||||
| Total Debt | 30.03 M | ||||
| Debt To Equity | 0.07 % | ||||
| Current Ratio | 7.58 X | ||||
| Book Value Per Share | 0.89 X | ||||
| Cash Flow From Operations | (42.82 M) | ||||
| Earnings Per Share | (1.12) X | ||||
| Market Capitalization | 320.92 M | ||||
| Total Asset | 155.31 M | ||||
| Retained Earnings | (440.28 M) | ||||
| Working Capital | 72.6 M | ||||
About Sophia Genetics Performance
By evaluating Sophia Genetics' fundamental ratios, stakeholders can gain valuable insights into Sophia Genetics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Sophia Genetics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Sophia Genetics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 100.86 | 140.34 | |
| Return On Tangible Assets | (0.49) | (0.52) | |
| Return On Capital Employed | (0.52) | (0.54) | |
| Return On Assets | (0.40) | (0.42) | |
| Return On Equity | (0.65) | (0.68) |
Things to note about Sophia Genetics SA performance evaluation
Checking the ongoing alerts about Sophia Genetics for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Sophia Genetics SA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Sophia Genetics SA had very high historical volatility over the last 90 days | |
| Sophia Genetics SA has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 65.17 M. Net Loss for the year was (61.27 M) with profit before overhead, payroll, taxes, and interest of 49.49 M. | |
| Sophia Genetics SA currently holds about 216.61 M in cash with (42.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.38. | |
| Sophia Genetics SA has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Can SOPHiA GENETICS SA stock maintain growth trajectory - Watch List Stock Market Timing Techniques - |
- Analyzing Sophia Genetics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Sophia Genetics' stock is overvalued or undervalued compared to its peers.
- Examining Sophia Genetics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Sophia Genetics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Sophia Genetics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Sophia Genetics' stock. These opinions can provide insight into Sophia Genetics' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Sophia Stock analysis
When running Sophia Genetics' price analysis, check to measure Sophia Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sophia Genetics is operating at the current time. Most of Sophia Genetics' value examination focuses on studying past and present price action to predict the probability of Sophia Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sophia Genetics' price. Additionally, you may evaluate how the addition of Sophia Genetics to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |